Respiratory Syncytial Virus Diagnostic Market Analysis, Upcoming Trends 2027

RSV Diagnostics Market Trends, Size and Insights by Method (Rapid Antigen Detection Tests, Molecular Diagnostic Tests, Others), By End-User (Hospital and Clinics, Clinical Laboratory, Others) – Global Forecast Till 2027

RSV Diagnostics Market Scenario

The RSV diagnostics market is expected to gain prominence over the forecast period. It is estimated that the global RSV diagnostics market is expected to register a CAGR ~ 10.4 % during the forecast period of 2018–2023.

GET FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/6217

RSV Diagnostics Market Segmentation

The global RSV diagnostics market has been segmented based on product, method, and end-user.Depending on the type of product, the market has been classified into kits and assays, instruments, and other products.

Method-wise, the global RSV diagnostics market has been considered for molecular diagnostics, rapid antigen detection test, gel microdroplets, flow cytometry, and others. Furthermore, the rapid antigen detection tests are sub-segmented into enzyme-linked immunosorbent assays, immunofluorescence assays, and other rapid antigen detection tests. The other type of rapid antigen detection tests can be segmented into chromatographic immunoassays and optical immunoassays.The end-users mentioned in the report include hospitals and clinics, clinical laboratories, home care, and others.

RSV Diagnostics Market Regional Outlook

The global RSV diagnostics market is segmented into the regional markets of the Americas, Asia Pacific, Europe, as well as the Middle East & Africa. The Americas will be the most lucrative market for RSV diagnostics on account of the rising incidences of RSV, growing healthcare expenditure and technological advancements in molecular diagnostics. As per the Centers for Disease Control and Prevention, over 57,000 children younger than five years old are hospitalized owing to RSV infection every year, in the United States (U.S). In order to bring down this abysmal number, various initiatives and programs are being introduced in the region, which means that the market will be doing excellent business in the region in the years to come. Meanwhile, Europe has landed the second spot in the global RSV diagnostics market, with factors like increasing automation in vitro diagnostics, rising occurrence of RSV diseases, and surging funding offered by the government backing the said growth. Considering the current status of the region, the data furnished by the University of Oxford states that more than 30,000 babies and children less than five years of age are expected to be hospitalized every year owing to RSV.

The RSV diagnostics market in Asia Pacific can be broken down into smaller markets in the countries of India, Japan, China, Republic of Korea, Australia and the rest of the region. The regional market is touted to be the fastest-growing globally as a result of the rise in the infectious disease which includes the RSV infection. Also, the increasing healthcare expenditure coupled with the surge in the demand for RSV disease diagnosis has taken the market to higher levels in the past few years. In addition, countries like India, China, and Japan are deemed to be growing at the fastest rate in the region with the expanding healthcare systems along with the growing government initiatives backing up these markets.

Showcasing a rather sluggish growth rate in the global market is the region of the Middle East and Africa, which despite various restraints holds immense potential. The market shows promise, with the support of various factors including the increasing awareness and high investments by private industry participants combined with the increasing incidences of RSV in children in the region.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/rsv-diagnostics-market-6217

Key VendorsBio-Rad Laboratories Inc., Abbott, F. Hoffman-La Roche Ltd., Danaher Corporation, Quest Diagnostics, Biocartis, Luminex, Hologic, Fast Track Diagnostics, Biomerieux, Becton, Dickinson, and Company (BD), Alere, Inc., Quidel Corporation, Thermo Fisher Scientific are among some of the top most companies in the RSV diagnostics market.

Latest News

May 2019SpeeDx Pty. Ltd. has gotten the clearance from the Australian Therapeutic Goods Administration (TGA) of their PlexPCR RespiVirus test. It makes use of the PlexPCR technology for detecting 11 types of pathogens known for causing viral respiratory-illnesses. In addition, this test also lets the laboratories process a greater number of samples in a limited period of shift compared to a conventional in-house test.

Browse other healthcare related report

Oral Thin Film Drugs Market

Needle Free Injection Market

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.